Literature DB >> 23743788

What is needed to eliminate new pediatric HIV infections: the contribution of model-based analyses.

Katie Doherty1, Andrea Ciaranello.   

Abstract

PURPOSE OF REVIEW: Computer simulation models can identify key clinical, operational, and economic interventions that will be needed to achieve the elimination of new pediatric HIV infections. In this review, we summarize recent findings from model-based analyses of strategies for prevention of mother-to-child HIV transmission (MTCT). RECENT
FINDINGS: In order to achieve elimination of MTCT (eMTCT), model-based studies suggest that scale-up of services will be needed in several domains: uptake of services and retention in care (the PMTCT 'cascade'), interventions to prevent HIV infections in women and reduce unintended pregnancies (the 'four-pronged approach'), efforts to support medication adherence through long periods of pregnancy and breastfeeding, and strategies to make breastfeeding safer and/or shorter. Models also project the economic resources that will be needed to achieve these goals in the most efficient ways to allocate limited resources for eMTCT. Results suggest that currently recommended PMTCT regimens (WHO Option A, Option B, and Option B+) will be cost-effective in most settings.
SUMMARY: Model-based results can guide future implementation science, by highlighting areas in which additional data are needed to make informed decisions and by outlining critical interventions that will be necessary in order to eliminate new pediatric HIV infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23743788      PMCID: PMC3799993          DOI: 10.1097/COH.0b013e328362db0d

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  44 in total

1.  Cost-effectiveness of using HAART in prevention of mother-to-child transmission in the DREAM-Project Malawi.

Authors:  Stefano Orlando; Maria Cristina Marazzi; Sandro Mancinelli; Giuseppe Liotta; Susanna Ceffa; Pietro Giglio; Ellard Alumando; Isabelle Ziegler; Mary Shawa; Leonardo Palombi
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

Review 2.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Authors:  M C Weinstein; J E Siegel; M R Gold; M S Kamlet; L B Russell
Journal:  JAMA       Date:  1996-10-16       Impact factor: 56.272

3.  Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.

Authors:  Kathleen M Powis; Laura Smeaton; Anthony Ogwu; Shahin Lockman; Scott Dryden-Peterson; Erik van Widenfelt; Jean Leidner; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

4.  Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic.

Authors:  Nicole C Schmidt; José Roman-Pouriet; Aracelis D Fernandez; Consuelo M Beck-Sagué; José Leonardo-Guerrero; Stephen W Nicholas
Journal:  Int J Gynaecol Obstet       Date:  2011-12-22       Impact factor: 3.561

5.  Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

Authors:  Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

6.  Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.

Authors:  Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

7.  Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.

Authors:  Abubaker Bedri; Berhanu Gudetta; Abdulhamid Isehak; Solomon Kumbi; Sileshi Lulseged; Yohannes Mengistu; Arvind V Bhore; Ramesh Bhosale; Venkat Varadhrajan; Nikhil Gupte; Jayagowri Sastry; Nishi Suryavanshi; Srikanth Tripathy; Francis Mmiro; Michael Mubiru; Carolyne Onyango; Adrian Taylor; Philippa Musoke; Clemensia Nakabiito; Aida Abashawl; Rahel Adamu; Gretchen Antelman; Robert C Bollinger; Patricia Bright; Mohammad A Chaudhary; Jacqueline Coberly; Laura Guay; Mary Glenn Fowler; Amita Gupta; Elham Hassen; J Brooks Jackson; Lawrence H Moulton; Uma Nayak; Saad B Omer; Lidia Propper; Malathi Ram; Vivian Rexroad; Andrea J Ruff; Anita Shankar; Sheryl Zwerski
Journal:  Lancet       Date:  2008-07-26       Impact factor: 79.321

Review 8.  Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis.

Authors:  Jean B Nachega; Olalekan A Uthman; Jean Anderson; Karl Peltzer; Sarah Wampold; Mark F Cotton; Edward J Mills; Yuh-Shan Ho; Jeffrey S A Stringer; James A McIntyre; Lynne M Mofenson
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

Review 9.  Cost-effectiveness of antiretroviral therapy for prevention.

Authors:  James G Kahn; Elliot A Marseille; Rod Bennett; Brian G Williams; Reuben Granich
Journal:  Curr HIV Res       Date:  2011-09       Impact factor: 1.581

10.  What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs.

Authors:  Mary Mahy; John Stover; Karusa Kiragu; Chika Hayashi; Priscilla Akwara; Chewe Luo; Karen Stanecki; Rene Ekpini; Nathan Shaffer
Journal:  Sex Transm Infect       Date:  2010-12       Impact factor: 3.519

View more
  5 in total

1.  Outcomes of prevention of mother to child transmission of the human immunodeficiency virus-1 in rural Kenya--a cohort study.

Authors:  Eunice Wambui Nduati; Amin Shaban Hassan; Miguel Garcia Knight; Daniel Muli Muema; Margaret Nassim Jahangir; Shalton Lwambi Mwaringa; Timothy Juma Etyang; Sarah Rowland-Jones; Britta Christina Urban; James Alexander Berkley
Journal:  BMC Public Health       Date:  2015-10-03       Impact factor: 3.295

2.  Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional survey.

Authors:  Nancy L Hancock; Carla J Chibwesha; Samuel Bosomprah; Jonathan Newman; Mwangelwa Mubiana-Mbewe; Elizabeth Siyama Sitali; Carolyn Bolton-Moore; Clara Mbwili-Muleya; Benjamin H Chi
Journal:  BMC Public Health       Date:  2016-05-12       Impact factor: 3.295

3.  Development and Implementation of a Mobile Phone-Based Prevention of Mother-To-Child Transmission of HIV Cascade Analysis Tool: Usability and Feasibility Testing in Kenya and Mozambique.

Authors:  Nami Kawakyu; Ruth Nduati; Khátia Munguambe; Joana Coutinho; Nancy Mburu; Georgina DeCastro; Celso Inguane; Andrew Zunt; Neil Abburi; Kenneth Sherr; Sarah Gimbel
Journal:  JMIR Mhealth Uhealth       Date:  2019-05-13       Impact factor: 4.773

4.  From transmission to transition: lessons learnt from the Thai paediatric antiretroviral programme.

Authors:  Olivia Tulloch; Sally Theobald; Jintanat Ananworanich; Sanchai Chasombat; Pope Kosalaraksa; Thidaporn Jirawattanapisal; Sudrak Lakonphon; Pagakrong Lumbiganon; Miriam Taegtmeyer
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

5.  Using Observational Data to Inform HIV Policy Change for Children and Youth.

Authors:  Annette H Sohn; Ali Judd; Lynne Mofenson; Marisa Vicari; Degu Jerene; Valeriane Leroy; Linda-Gail Bekker; Mary-Ann Davies
Journal:  J Acquir Immune Defic Syndr       Date:  2018-08-15       Impact factor: 3.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.